181 stories from 21 sources
The week in Medicine and Healthcare
Click on a headline to see stories that shaped it.
Threads
8 threads
The Ebola outbreak in eastern Congo grew from more than 1,700 deaths to over 4,000 reported cases, while late treatment, disrupted health-worker operations, and strained surveillance worsened the response. Vaccine trials gained urgency as officials sought evidence without delaying protection.
The cyclospora outbreak reached more than 10,000 illnesses and two linked deaths before reports declined in Michigan. The outbreak exposed persistent weaknesses in tracing contamination and damaged demand for restaurant salads and other fresh foods.
AstraZeneca and Bristol Myers Squibb repeatedly surfaced in talks over a roughly $400 billion combination that would reshape the drug industry. Investors and observers focused on patent losses, financing, integration, regulatory scrutiny, and AstraZeneca’s pursuit of greater U.S. scale.
Strong Zepbound and Mounjaro sales drove Lilly to raise its 2026 outlook, while Novo Nordisk struggled with a disappointing Wegovy pill result, falling prices, and lost market share. Lilly also expanded early access to unapproved retatrutide, adding pressure around supply, safety, and coverage.
A Mexican jalapeño-linked Salmonella outbreak sickened 345 people across 27 states, prompting a recall. Investigators continued assessing the contamination’s full scope as the broad geographic spread left ongoing exposure risk.
Joe Biden’s prostate cancer was disclosed as having spread to his bones and elsewhere, with severe pain and debilitating effects. The repeated disclosure established more advanced disease than earlier descriptions, while the full extent and treatment plan remained unclear.
Health officials consulted technology companies and other stakeholders about accelerating clinical AI, while looser rules could shift safety, compliance, and performance risks onto hospitals and clinicians. Questions over AI scribes, reimbursement, accuracy, and accountability remained central as specialized medical AI gained investor attention.
New York City detected nearly twice as many West Nile-positive mosquito pools as at the same point last year. Officials expanded mosquito control and prevention efforts before confirmed human transmission appeared.
Day’s Recap